远红外线疗法对维持性血液透析患者自体动静脉内瘘维护的影响

摘要

Objective:To investigate the effectiveness of far - infrared therapy(FIR)for improving arteriovenous fistula filling degree,blood flow,dialysis quality and comfort among maintenance hemodialysis patients. Methods:60 patinents with hemodialysis therapy used an FIR before and six months after the use of AVF flow,dialysis,blood flow can be achieved,dialysis blood pressure,hypertension and hypotension in hemodialysis occurrences,von Willebrand fac-tor activity and the like changes. Results:After 6 months with FIR therapy the AVF flow and blood flow was significantly higher than hemodialysis treatment (P ﹤ 0. 05),dialysis adequacy is also higher than before treatment(P ﹤ 0. 05),von Willebrand factor were lower than before treatment(P ﹤ 0. 05),hyper-tension and hypotension dialysis times lower than before treatment(P ﹤ 0. 05). Conclusions:(1)FIR therapy is safe,reliable,does not increase the difficulty of nurse puncture.(2)FIR therapy can improve the flow and dialysis AVF blood flow,improve dialysis adequacy.(3)FIR therapy for dialysis patients in the regulation of blood pressure with two - way,help to improve tolerance for dialysis patients,improve dialysis comfort.(4)FIR therapy will help to improve AVF vascular inflammation and endothelial function.%目的：探讨远红外线（FIR）疗法对于改善维持性血液透析患者自体动静脉内瘘（AVF）状况、减少 AVF 并发症、提高 AVF 充盈度、改善血流量，进而改善患者透析质量及舒适度等方面的影响。方法：比较我院血液净化中心60例采用 AVF 进行维持性血液透析的患者在使用 FIR疗法前和使用6个月后 AVF 流量、透析中可达到血流量、透析中血压、透析中高血压及低血压发生次数、血管性血友病因子活性等变化情况。结果：FIR 疗法使用6个月后患者 AVF 流量和透析中血流量明显高于治疗前（P ﹤0．05），透析充分性亦高于治疗前（P ﹤0．05），血管性血友病因子活性低于治疗前（P ﹤0．05），透析中高血压及低血压发生次数低于治疗前（P ﹤0．05）。结论：（1）FIR 疗法安全、可靠，不会增加护士穿刺难度。（2）FIR 疗法能提高 AVF 流量及透析中血流量，提高透析充分性。（3）FIR 疗法对于患者透析中的血压具有双向调节作用，有利于改善患者对于透析的耐受度，改善透析舒适度。（4）FIR 疗法有利于改善 AVF 血管炎症状态及内皮功能。